Approval · Notice of Compliance 9163 · 2007
CYMBALTA: Notice of Compliance 9163
Issued November 1, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9163
- Date
- November 1, 2007
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antidepressant / analgesic
Products in this notice
Medicinal ingredients
- DULOXETINE HYDROCHLORIDE 30 MG per CAP
- DULOXETINE HYDROCHLORIDE 60 MG per CAP